Please login to the form below

Not currently logged in
Email:
Password:

OxyContin

This page shows the latest OxyContin news and features for those working in and with pharma, biotech and healthcare.

Endo faces industry-first FDA call to pull its opioid painkiller

Endo faces industry-first FDA call to pull its opioid painkiller

Previously Purdue Pharma’s opioid painkiller Oxycontin was removed from the market when an abuse-resistant form became available, but the privately-held pharmaceutical company removed the drug from the market

Latest news

  • Purdue gets FDA nod for abuse-deterrent painkiller Purdue gets FDA nod for abuse-deterrent painkiller

    Purdue already sells an abuse-deterrent product version of its OxyContin (oxycodone) product, and earlier this year got approval in the US for another around-the-clock opioid painkiller, Targiniq ER,

  • FDA approves pain drug that has reduced risk of abuse FDA approves pain drug that has reduced risk of abuse

    The pain relieving effects in Targiniq ER come from oxycodone – the active ingredient in Purdue's existing OxyContin - although the new product also contain naloxone, which reverses the effects of opioid ... The availability of the abuse-deterrent

  • A will of iron A will of iron

    OxyContin – Purdue Pharma. Author. Public.

  • FDA bars generic version of Purdue’s painkiller OxyContin FDA bars generic version of Purdue’s painkiller OxyContin

    FDA bars generic version of Purdue’ s painkiller OxyContin. New abuse-deterrent formulation means original version no longer has positive benefit-to-risk profile. ... US regulators have banned generic versions of Purdue Pharma's painkiller OxyContin

  • Opioid analgesics

    OxyContin could be considered as Purdue Pharma's 'phoenix'. It is a reformulation of controlled-release oxycodone that has less potential for abuse. ... Nevertheless, the confidence that the reformulated OxyContin has remedied these problems appears to

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    Our agency was responsible for the EU launch of OxyContin and the first sublingual formulation of fentanyl, a powerful opioid that is abused by many drug addicts. ... So we are acutely aware of the devastation caused by the opioid epidemic in the US, and

  • "Legal highs" ruling leaves illegal labs laughing

    Our agency was responsible for the EU launch of OxyContin and the first sublingual formulation of fentanyl, a powerful opioid that is abused by many drug addicts. ... So we are acutely aware of the devastation caused by the opioid epidemic in the US, and

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics